B
IRWD icon

Braidwell’s Ironwood Pharmaceuticals IRWD Stock Holding History

Braidwell’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,622,584
Closed -$9.74M – 61
2025
Q1 		$9.74M Buy
6,622,584
+1,182,307
+22% +$2.82M 0.34% 51
2024
Q4 		$24.1M Buy
5,440,277
+1,002,045
+23% +$4.07M 0.71% 48
2024
Q3 		$18.3M Hold
4,438,232
– – 0.52% 55
2024
Q2 		$28.9M Buy
4,438,232
+948,389
+27% +$6.71M 0.91% 39
2024
Q1 		$30.4M Buy
+3,489,843
New +$42.3M 0.98% 40
2023
Q4 		– Sell
-1,348,099
Closed -$13M – 82
2023
Q3 		$13M Buy
+1,348,099
New +$13.2M 0.41% 70

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Braidwell's IRWD Position: Q2 2025 in Review

Braidwell sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 6,622,584 shares — an estimated $9.74M sold.

Braidwell first reported a position in IRWD in Q3 2023 and held it in 6 quarters. The position peaked at $30.4M in Q1 2024. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Braidwell reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Braidwell sold 6,622,584 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $9.74M.
  • Braidwell first reported a position in Ironwood Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Braidwell's Ironwood Pharmaceuticals position peaked at $30.4M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Braidwell's 13F filing for Q2 2025, filed 14 Aug 2025.